Systemic Inflammatory Indices and CRP-to-Albumin Ratio in Association with Restenosis Following Percutaneous Mitral Balloon Valvuloplasty: An Observational Cohort Study-Uncorrected Proof

OBJECTIVE: Percutaneous mitral balloon valvuloplasty (PMBV) is the treatment of choice for suitable patients with rheumatic mitral stenosis, but restenosis remains clinically relevant. This study evaluated whether preprocedural inflammatory indices are associated with restenosis after PMBV. METHOD: We retrospectively evaluated 141 consecutive patients who underwent successful PMBV. Preprocedural neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammatory response index (SIRI), C-reactive protein (CRP), CRP-to-albumin ratio (CAR), and serum uric acid were assessed. Restenosis was defined as a mitral valve area (MVA) <1.5 cm² during follow-up. Kaplan-Meier and Cox regression analyses were used as the primary analyses. Logistic regression with 1,000-bootstrap internal validation was performed as a secondary analysis. Multivariable models were adjusted for the Wilkins score and relevant clinical covariates. RESULTS: During a median follow-up of 36 months (IQR, 28-44), restenosis occurred in 33 patients (23.4%). PLR, MLR, CAR, and uric acid levels were higher in patients with restenosis after false discovery rate correction (all q<0.05). In the multivariable Cox analysis, the Wilkins score was the sole independent predictor of restenosis (HR, 2.14; 95% CI, 1.43-3.20; P < 0.001), whereas CAR (HR, 1.18; 95% CI, 0.94-1.49; P = 0.16) and uric acid (HR, 1.09; 95% CI, 0.91-1.30; P = 0.34) were not independently associated with restenosis. CAR demonstrated an AUC of 0.71 (95% CI, 0.61-0.81). Adding CAR to the Wilkins score did not improve discrimination (ΔAUC=0.02; NRI=0.11, P = 0.26; IDI=0.019, P = 0.11). CONCLUSION: The Wilkins score was the sole independent predictor of restenosis after PMBV. Preprocedural CAR and uric acid were associated with restenosis in unadjusted analyses but provided no independent or incremental prognostic value beyond established clinical and echocardiographic factors.

Authors

Institutions

Publication Details

Journal
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Published
2026-11-17
DOI
https://doi.org/10.5543/tkda.2026.65755
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Systemic Inflammatory Indices and CRP-to-Albumin Ratio in Association with Restenosis Following Percutaneous Mitral Balloon Valvuloplasty: An Observational Cohort Study-Uncorrected Proof

Cuma Süleymanoğlu, Ramazan Topsakal, Fuat Polat, Ali Doğan et al.
2 links
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Inflammatory Biomarkers in Disease Prognosis
article

Systemic Inflammatory Indices and CRP-to-Albumin Ratio in Association with Restenosis Following Percutaneous Mitral Balloon Valvuloplasty: An Observational Cohort Study-Uncorrected Proof

Cuma Süleymanoğlu, Ramazan Topsakal, Fuat Polat, Ali Doğan, Cemre Turgul, Aigul Zhusupova
article en

Abstract

OBJECTIVE: Percutaneous mitral balloon valvuloplasty (PMBV) is the treatment of choice for suitable patients with rheumatic mitral stenosis, but restenosis remains clinically relevant. This study evaluated whether preprocedural inflammatory indices are associated with restenosis after PMBV. METHOD: We retrospectively evaluated 141 consecutive patients who underwent successful PMBV. Preprocedural neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammatory response index (SIRI), C-reactive protein (CRP), CRP-to-albumin ratio (CAR), and serum uric acid were assessed. Restenosis was defined as a mitral valve area (MVA) <1.5 cm² during follow-up. Kaplan-Meier and Cox regression analyses were used as the primary analyses. Logistic regression with 1,000-bootstrap internal validation was performed as a secondary analysis. Multivariable models were adjusted for the Wilkins score and relevant clinical covariates. RESULTS: During a median follow-up of 36 months (IQR, 28-44), restenosis occurred in 33 patients (23.4%). PLR, MLR, CAR, and uric acid levels were higher in patients with restenosis after false discovery rate correction (all q<0.05). In the multivariable Cox analysis, the Wilkins score was the sole independent predictor of restenosis (HR, 2.14; 95% CI, 1.43-3.20; P < 0.001), whereas CAR (HR, 1.18; 95% CI, 0.94-1.49; P = 0.16) and uric acid (HR, 1.09; 95% CI, 0.91-1.30; P = 0.34) were not independently associated with restenosis. CAR demonstrated an AUC of 0.71 (95% CI, 0.61-0.81). Adding CAR to the Wilkins score did not improve discrimination (ΔAUC=0.02; NRI=0.11, P = 0.26; IDI=0.019, P = 0.11). CONCLUSION: The Wilkins score was the sole independent predictor of restenosis after PMBV. Preprocedural CAR and uric acid were associated with restenosis in unadjusted analyses but provided no independent or incremental prognostic value beyond established clinical and echocardiographic factors.

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of CardiologyVol. 54(54)
Ministry of Health (TR), Kayseri Eğitim ve Araştırma Hastanesi (TR), Erciyes University (TR)
Good health and well-being
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon